Mounjaro (tirzepatide) is a once-weekly subcutaneous injection developed by Eli Lilly and approved by the MHRA for weight management in adults in the UK
What is genuinely impressive: The mechanistic science behind the three-strain formulation is sound
The investigators informed the eligible patients regarding the aims, methods, anticipated benefits and potential hazards of the study, and provided them with an information sheet
This ALCAR regime was based on previous work showing behavioural improvements after treatment with ALCAR (Schaevitz et al, 2012
[DOI] [PMC free article] [PubMed] [Google Scholar] 484.Piscaer I., van den Ouweland J.M.W., Vermeersch K., Reynaert N.L., Franssen F.M.E., Keene S., Wouters E.F.M., Janssens W., Vermeer C., Janssen R